Luncheon Symposium 2【Ferring】

In this symposium, participants will gain practical insights into:

Best practices for administering subcutaneous injections of degarelix, including techniques to minimize injection-site reactions and enhance patient comfort.

Strategies for cardiovascular risk assessment and management in prostate cancer patients undergoing hormonal therapies, emphasizing the importance of multidisciplinary collaboration between cardiology and uro-oncology experts.

These topics will be illustrated through real-world case studies and expert discussions, providing attendees with actionable knowledge to optimize patient outcomes.